About Enhancer
| Enhancer ID: | E_02903 |
| Species: | Homo sapiens |
| Position : | chr2:85750614-85811383   |
| Year: | 2016 |
| Title: | Chromatin interactions and candidate genes at ten prostate cancer risk loci. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 26979803 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | LCL-32370 |
| Experiment Type: | Chromatin interaction assay; TF binding assay; Gene expression assay |
| High Throughput Method: | Capture 3C-seq; ChIP-seq; RNA-seq; SNP genotyping array; 3C; eQTL analysis |
| Low Throughput Method: | 3C-qPCR; RT-qPCR |
About Target Gene
| Target gene : | NA |
About TF
| TF name : | FOXA1 |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| FOXA1 | AndrogenReceptor | netpath | 167 |
| FOXA1 | Direct p53 effectors | pid | 141 |
| FOXA1 | FOXA1 transcription factor network | pid | 45 |
| FOXA1 | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
| FOXA1 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |
Enhancer Associated Network
Overlapping Enhancers (hg19)
23 found
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02854 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02855 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02856 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02857 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02870 | chr2:85750614-85811383 | prostate gland | prostate epithelial cell | NA |
| E_02871 | chr2:85750614-85811383 | prostate gland | prostate epithelial cell | NA |
| E_02872 | chr2:85750614-85811383 | prostate gland | prostate epithelial cell | NA |
| E_02873 | chr2:85750614-85811383 | prostate gland | prostate epithelial cell | NA |
| E_02893 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02894 | chr2:85750614-85811383 | blood | NA | NA |
| E_02895 | chr2:85750614-85811383 | blood | NA | NA |
| E_02896 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02897 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02898 | chr2:85750614-85811383 | blood | NA | NA |
| E_02899 | chr2:85750614-85811383 | blood | NA | NA |
| E_02900 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02901 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02902 | chr2:85750614-85811383 | blood | NA | NA |
| E_02904 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02905 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02906 | chr2:85750614-85811383 | blood | NA | NA |
| E_02907 | chr2:85750614-85811383 | blood | NA | NA |
| E_02908 | chr2:85750614-85811383 | prostate gland | NA | NA |
Expression of Target Genes for the Enhancer